Denmark
Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data
Viking Therapeutics stock jumped 25% to $87 per share on Tuesday after the pharmaceutical company released promising clinical trial results for its experimental weight loss pill. It’s the latest development in the race among several pharmaceutical co
Related
Share this page
Guest Posts by Easy Branches